- Accesswire•2 days agoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 2, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" ...
- GlobeNewswire•2 days agoINVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm
NEW YORK, Dec. 02, 2016-- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. and its President and CEO Christopher R. Anzalone and CFO Kenneth A. Myszkowski in ...
ARWR : Summary for Arrowhead Pharmaceuticals, Inc. - Yahoo Finance
Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||1.34 x 100|
|Ask||1.50 x 500|
|Day's Range||1.33 - 1.48|
|52 Week Range||1.32 - 8.22|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.02|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|